`This is an outstanding piece of scholarship. It will serve as a powerful stimulant for new research in the field and as a reliable guide for practitioners.'---Calestous Juma, Harvard University, USA
Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation.
An international group of scholars from a range of disciplines - economic geography, health law, business, philosophy, history, public health, management - examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems.
Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.
'This is an outstanding piece of scholarship. It will serve as a powerful stimulant for new research in the field and as a reliable guide for practitioners.' - Calestous Juma, Harvard University, US
Contents: Introduction David Castle PART I: INTELLECTUAL PROPERTY RIGHTS IN INNOVATION SYSTEMS 1. Introduction David Castle 1. Are Intellectual Property Rights Quanta of Innovation? J. Adam Holbrook 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context BjA rn Asheim, Finn Valentin and Christian Zeller 3. Intellectual Property Rights Policy for Gene-Related Inventions - Toward Optimum Balance Between Public and Private Ownership Koichi Sumikura PART II: INTELLECTUAL PROPERTY MANAGEMENT IN BIOTECHNOLOGY Introduction Karen L. Durell 4. Fundamentals of Intellectual Property Management Patrick H. Sullivan 5. Making a Return on R&D: A Business Perspective Sharon Oriel 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology Karen L. Durell and E. Richard Gold PART III: INTELLECTUAL PROPERTY RIGHTS IN RELATION TO OTHER MEASURES OF INNOVATION Introduction L. Martin Cloutier and David Castle 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements Marc Ingham, Cecile Ayerbe, Emmanuel Metais and Liliana Mitkova 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation Clinton W. Francis 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes L. Martin Cloutier and Susanne Sirois PART IV: BEYOND PATENT LENGTH Introduction Amy J. Glass and Fabricio X. Nunez 10. Open Development: Is the 'Open Source' Analogy Relevant to Biotechnology? Alan G. Isaac and Walter G. Park 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits Christopher May 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology F. Scott Kieff PART V: INNOVATION GOVERNANCE Introduction Tania Bubela 13. Accessibility of Biological Data: A Role for the European Database Right? Jasper A. Bovenberg 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance? Timothy Caulfield 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries Sachin Chaturvedi PART VI: NATIONAL, INTERNATIONAL AND HISTORICAL COMPARISONS Introduction Abdallah S. Daar and David Castle 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons Richard Y. Boadi 17. Intellectual Property, Information and Divergences in Economic Development - Institutional Patterns and Outcomes circa 1421-2000 Ian Inkster 18. Watch What You Export: The History of Medical Exceptions from Patentability Tina Piper Index